Mr. David J. Main

Biography

Mr. Main has over 25 years of experience in the pharmaceutical industry and brings a demonstrated ability to grow and finance pharmaceutical development companies. As a founder of Aquinox, Mr. Main has overseen the advancement of the company’s lead product, rosiptor (AQX-1125), from a target validation program to Phase 3 and is preparing to transition the Company to a commercially focused organization. During this time he has also been responsible for the transition of Aquinox from a private to a NASDAQ-listed public company with over US$250 million raised to date in equity capital. Mr. Main was formerly the President and CEO of INEX Pharmaceuticals Corp. and, prior to INEX, was a Vice President at QLT Inc., one of Canada’s inaugural biotech companies. Mr. Main began his career as a licensed pharmacist at the Royal Columbian Hospital in New Westminster, B.C. He holds a B.Sc. (Pharmacy) and an MBA from the University of British Columbia (UBC). Mr. Main formerly served as the Chair of LifeSciences BC (formerly BC Biotech) and BIOTECanada. He is the current Chairman of Accel-Rx, a Director of BIO.org, and contributes his time to other not-for-profit organizations.

Research Interest

Pharmaceutical Science, Finance and Pharamaceutical development